OrganiGram Holdings Inc
TSX:OGI

Watchlist Manager
OrganiGram Holdings Inc Logo
OrganiGram Holdings Inc
TSX:OGI
Watchlist
Price: 2.15 CAD 2.14% Market Closed
Market Cap: 233.4m CAD
Have any thoughts about
OrganiGram Holdings Inc?
Write Note

Intrinsic Value

The intrinsic value of one OGI stock under the Base Case scenario is 1.21 CAD. Compared to the current market price of 2.15 CAD, OrganiGram Holdings Inc is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OGI Intrinsic Value
1.21 CAD
Overvaluation 44%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
OrganiGram Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for OGI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about OGI?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about OrganiGram Holdings Inc

Provide an overview of the primary business activities
of OrganiGram Holdings Inc.

What unique competitive advantages
does OrganiGram Holdings Inc hold over its rivals?

What risks and challenges
does OrganiGram Holdings Inc face in the near future?

Summarize the latest earnings call
of OrganiGram Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for OrganiGram Holdings Inc.

Provide P/S
for OrganiGram Holdings Inc.

Provide P/E
for OrganiGram Holdings Inc.

Provide P/OCF
for OrganiGram Holdings Inc.

Provide P/FCFE
for OrganiGram Holdings Inc.

Provide P/B
for OrganiGram Holdings Inc.

Provide EV/S
for OrganiGram Holdings Inc.

Provide EV/GP
for OrganiGram Holdings Inc.

Provide EV/EBITDA
for OrganiGram Holdings Inc.

Provide EV/EBIT
for OrganiGram Holdings Inc.

Provide EV/OCF
for OrganiGram Holdings Inc.

Provide EV/FCFF
for OrganiGram Holdings Inc.

Provide EV/IC
for OrganiGram Holdings Inc.

Show me price targets
for OrganiGram Holdings Inc made by professional analysts.

What are the Revenue projections
for OrganiGram Holdings Inc?

How accurate were the past Revenue estimates
for OrganiGram Holdings Inc?

What are the Net Income projections
for OrganiGram Holdings Inc?

How accurate were the past Net Income estimates
for OrganiGram Holdings Inc?

What are the EPS projections
for OrganiGram Holdings Inc?

How accurate were the past EPS estimates
for OrganiGram Holdings Inc?

What are the EBIT projections
for OrganiGram Holdings Inc?

How accurate were the past EBIT estimates
for OrganiGram Holdings Inc?

Compare the revenue forecasts
for OrganiGram Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of OrganiGram Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of OrganiGram Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of OrganiGram Holdings Inc compared to its peers.

Compare the P/E ratios
of OrganiGram Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing OrganiGram Holdings Inc with its peers.

Analyze the financial leverage
of OrganiGram Holdings Inc compared to its main competitors.

Show all profitability ratios
for OrganiGram Holdings Inc.

Provide ROE
for OrganiGram Holdings Inc.

Provide ROA
for OrganiGram Holdings Inc.

Provide ROIC
for OrganiGram Holdings Inc.

Provide ROCE
for OrganiGram Holdings Inc.

Provide Gross Margin
for OrganiGram Holdings Inc.

Provide Operating Margin
for OrganiGram Holdings Inc.

Provide Net Margin
for OrganiGram Holdings Inc.

Provide FCF Margin
for OrganiGram Holdings Inc.

Show all solvency ratios
for OrganiGram Holdings Inc.

Provide D/E Ratio
for OrganiGram Holdings Inc.

Provide D/A Ratio
for OrganiGram Holdings Inc.

Provide Interest Coverage Ratio
for OrganiGram Holdings Inc.

Provide Altman Z-Score Ratio
for OrganiGram Holdings Inc.

Provide Quick Ratio
for OrganiGram Holdings Inc.

Provide Current Ratio
for OrganiGram Holdings Inc.

Provide Cash Ratio
for OrganiGram Holdings Inc.

What is the historical Revenue growth
over the last 5 years for OrganiGram Holdings Inc?

What is the historical Net Income growth
over the last 5 years for OrganiGram Holdings Inc?

What is the current Free Cash Flow
of OrganiGram Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for OrganiGram Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
OrganiGram Holdings Inc

Current Assets 205.7m
Cash & Short-Term Investments 80.1m
Receivables 29.9m
Other Current Assets 95.7m
Non-Current Assets 149.1m
Long-Term Investments 34.9m
PP&E 95.4m
Intangibles 8.8m
Other Non-Current Assets 10m
Current Liabilities 47.9m
Accounts Payable 39.7m
Other Current Liabilities 8.2m
Non-Current Liabilities 11m
Long-Term Debt 39k
Other Non-Current Liabilities 11m
Efficiency

Earnings Waterfall
OrganiGram Holdings Inc

Revenue
161.2m CAD
Cost of Revenue
-148.3m CAD
Gross Profit
12.9m CAD
Operating Expenses
-92.9m CAD
Operating Income
-80m CAD
Other Expenses
7m CAD
Net Income
-73m CAD

Free Cash Flow Analysis
OrganiGram Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Organigram demonstrated robust performance in Q3 fiscal 2024, with a 25% year-over-year revenue growth and a 9% sequential increase. Enhanced operating efficiencies uplifted gross margins from 19% to 36%. The company recorded a net income of $2.8 million compared to a previous net loss. Operating expenses were reduced by 20%, while adjusted EBITDA turned positive to $3.5 million. Organigram is optimistic about fiscal 2024, forecasting further improvements. Continued innovation, cost management, and strong international demand, particularly in Germany, are expected to drive future growth.

What is Earnings Call?
Fundamental Scores

OGI Profitability Score
Profitability Due Diligence

OrganiGram Holdings Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
19/100
Profitability
Score

OrganiGram Holdings Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

OGI Solvency Score
Solvency Due Diligence

OrganiGram Holdings Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
68/100
Solvency
Score

OrganiGram Holdings Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OGI Price Targets Summary
OrganiGram Holdings Inc

Wall Street analysts forecast OGI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OGI is 3.79 CAD with a low forecast of 2.53 CAD and a high forecast of 5.51 CAD.

Lowest
Price Target
2.53 CAD
17% Upside
Average
Price Target
3.79 CAD
76% Upside
Highest
Price Target
5.51 CAD
156% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for OGI?

Click here to dive deeper.

Dividends

OrganiGram Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for OGI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

OGI News

Other Videos

Profile

OrganiGram Holdings Inc Logo
OrganiGram Holdings Inc

Country

Canada

Industry

Pharmaceuticals

Market Cap

223.2m CAD

Dividend Yield

0%

Description

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. The company is headquartered in Moncton, New Brunswick. The company went IPO on 2011-11-24. Organigram is a licensed producer of cannabis and extract-based products. The firm is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. The company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. Organigram distributes its products mainly through the Company’s online store or by phone. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including The Edison Cannabis Company, SHRED, ANKR Organics, Indi, Bag o’ Buds and Trailblazer.

Contact

NEW BRUNSWICK
Moncton
35A English Dr
+15063841571.0
www.organigram.ca

IPO

2011-11-24

Employees

-

Officers

CEO & Director
Ms. Beena G. Goldenberg
Chief Legal Officer & Corporate Secretary
Ms. Helen Martin
Chief Commercial Officer
Mr. Timothy Emberg
Chief Strategy Officer
Mr. Paolo De Luca C.A., C.F.A
Chief Financial Officer
Mr. Greg Guyatt C.A., CPA
Senior Vice President of Operations
Ms. Nathalie Batten
Show More
Chief Information Officer
Mr. Geoff Riggs
Director of Investor Relations
Max Schwartz
Senior Vice President of Marketing & Communications
Ms. Megan Amber McCrae
Chief People Officer
Ms. Katrina May McFadden
Show Less

See Also

Discover More
What is the Intrinsic Value of one OGI stock?

The intrinsic value of one OGI stock under the Base Case scenario is 1.21 CAD.

Is OGI stock undervalued or overvalued?

Compared to the current market price of 2.15 CAD, OrganiGram Holdings Inc is Overvalued by 44%.

Back to Top